Loading clinical trials...
Loading clinical trials...
Study clinical context Cerebral aspergillosis (CA) is a rare location of invasive aspergillosis (IA), associated with a high morbidity and mortality. Since 2002, voriconazole is the recommended first ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Imagine Institute
NCT03717623 · Posaconazole, Pharmacokinetics, and more
NCT06382922 · Invasive Aspergillosis
NCT06583512 · Invasive Aspergillosis, Antifungal Therapy
NCT06028451 · Invasive Aspergillosis
NCT01430663 · Invasive Aspergillosis
Hôpital Necker-Enfants Malades
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions